| 3.2 |
9.5 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 2.5 |
7.5 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 2.5 |
7.4 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 2.1 |
6.2 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 2.0 |
8.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 2.0 |
7.9 |
GO:0003360 |
brainstem development(GO:0003360) |
| 1.9 |
5.7 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.8 |
5.5 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 1.8 |
7.2 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 1.7 |
5.1 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 1.7 |
8.4 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 1.7 |
5.1 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 1.7 |
5.0 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 1.7 |
1.7 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 1.6 |
8.1 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 1.6 |
4.9 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 1.5 |
10.5 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 1.5 |
5.9 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 1.5 |
4.4 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.4 |
4.3 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 1.4 |
4.2 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 1.4 |
6.8 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.3 |
4.0 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 1.3 |
3.9 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 1.3 |
3.8 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 1.3 |
3.8 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 1.3 |
3.8 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 1.2 |
13.7 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 1.2 |
9.9 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 1.2 |
7.4 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 1.2 |
2.4 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 1.2 |
5.9 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 1.2 |
3.5 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.1 |
5.7 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 1.1 |
5.6 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 1.1 |
3.3 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 1.1 |
5.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 1.1 |
4.4 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 1.1 |
2.1 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.1 |
4.3 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 1.1 |
3.2 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 1.0 |
4.2 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 1.0 |
7.2 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 1.0 |
9.2 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 1.0 |
4.1 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.0 |
3.0 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 1.0 |
3.0 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 1.0 |
2.9 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 1.0 |
13.4 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.9 |
2.8 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.9 |
5.6 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.9 |
3.7 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.9 |
2.8 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.9 |
2.7 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.9 |
2.7 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.9 |
2.7 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.9 |
9.9 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.9 |
1.8 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 0.9 |
2.7 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.9 |
5.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.9 |
3.5 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.9 |
0.9 |
GO:1900133 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 0.9 |
3.4 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.9 |
0.9 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.8 |
3.4 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.8 |
5.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.8 |
3.4 |
GO:2000705 |
regulation of dense core granule biogenesis(GO:2000705) |
| 0.8 |
0.8 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.8 |
0.8 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.8 |
2.5 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.8 |
4.1 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.8 |
3.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.8 |
0.8 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.8 |
1.6 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.8 |
4.9 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.8 |
3.3 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.8 |
2.4 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.8 |
0.8 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.8 |
6.5 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.8 |
2.4 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.8 |
2.4 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.8 |
1.6 |
GO:0002645 |
positive regulation of tolerance induction(GO:0002645) |
| 0.8 |
1.6 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.8 |
2.3 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.8 |
3.9 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.8 |
5.4 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.8 |
3.1 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.8 |
3.1 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.8 |
3.8 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.8 |
3.1 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.8 |
0.8 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.8 |
1.5 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.8 |
5.3 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.8 |
3.8 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 0.8 |
0.8 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.7 |
3.7 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.7 |
2.2 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.7 |
2.2 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.7 |
2.2 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.7 |
7.4 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.7 |
2.9 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.7 |
3.7 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.7 |
2.9 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.7 |
2.2 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.7 |
2.9 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.7 |
2.9 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.7 |
1.4 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
| 0.7 |
3.6 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.7 |
8.7 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.7 |
0.7 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.7 |
3.6 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.7 |
1.4 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.7 |
2.8 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.7 |
1.4 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.7 |
2.8 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.7 |
2.8 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.7 |
0.7 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 0.7 |
2.1 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.7 |
1.4 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.7 |
6.1 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.7 |
2.0 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
| 0.7 |
0.7 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.7 |
0.7 |
GO:0071864 |
positive regulation of cell proliferation in bone marrow(GO:0071864) |
| 0.7 |
2.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.7 |
6.6 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.7 |
2.0 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.7 |
0.7 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.7 |
2.0 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.7 |
1.3 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.7 |
3.9 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.7 |
4.6 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.7 |
0.7 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) |
| 0.7 |
2.0 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.7 |
1.3 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.7 |
0.7 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.6 |
0.6 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.6 |
3.2 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.6 |
5.1 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.6 |
3.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.6 |
1.9 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.6 |
1.9 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.6 |
3.8 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.6 |
1.9 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
| 0.6 |
1.9 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.6 |
1.9 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.6 |
1.2 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.6 |
0.6 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.6 |
0.6 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.6 |
8.0 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.6 |
0.6 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.6 |
3.7 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.6 |
2.5 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.6 |
2.4 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.6 |
6.0 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.6 |
2.4 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.6 |
4.1 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.6 |
1.8 |
GO:0072172 |
ureteric bud formation(GO:0060676) mesonephric tubule formation(GO:0072172) |
| 0.6 |
0.6 |
GO:1902302 |
regulation of potassium ion export(GO:1902302) |
| 0.6 |
5.9 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.6 |
7.1 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.6 |
1.2 |
GO:0003356 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.6 |
1.7 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.6 |
2.9 |
GO:1902165 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 0.6 |
0.6 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.6 |
1.1 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.6 |
3.4 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.6 |
1.7 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.6 |
3.4 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.6 |
8.4 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.6 |
1.7 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 0.6 |
1.7 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.5 |
0.5 |
GO:0021895 |
cerebral cortex neuron differentiation(GO:0021895) |
| 0.5 |
4.4 |
GO:1900107 |
regulation of nodal signaling pathway(GO:1900107) |
| 0.5 |
1.6 |
GO:0060468 |
prevention of polyspermy(GO:0060468) |
| 0.5 |
1.1 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.5 |
6.5 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.5 |
0.5 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.5 |
1.1 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
| 0.5 |
1.1 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.5 |
1.6 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.5 |
0.5 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.5 |
1.1 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.5 |
2.1 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.5 |
9.0 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.5 |
0.5 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.5 |
1.6 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.5 |
3.7 |
GO:1903423 |
positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.5 |
2.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.5 |
4.7 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.5 |
3.6 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.5 |
0.5 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.5 |
1.0 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.5 |
0.5 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.5 |
4.6 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.5 |
3.5 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.5 |
5.0 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.5 |
2.0 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.5 |
3.0 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.5 |
0.5 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.5 |
2.0 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.5 |
8.0 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.5 |
1.5 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.5 |
1.5 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.5 |
7.4 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.5 |
5.9 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.5 |
1.5 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.5 |
1.5 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.5 |
2.5 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.5 |
0.5 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.5 |
0.5 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.5 |
1.0 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.5 |
1.0 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.5 |
4.4 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.5 |
0.5 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 0.5 |
5.3 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.5 |
1.9 |
GO:0072131 |
kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
| 0.5 |
5.8 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.5 |
2.9 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.5 |
1.9 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.5 |
2.4 |
GO:0046668 |
regulation of retinal cell programmed cell death(GO:0046668) |
| 0.5 |
2.4 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.5 |
1.9 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.5 |
2.9 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.5 |
0.5 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.5 |
1.4 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.5 |
4.7 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.5 |
0.9 |
GO:0071548 |
response to dexamethasone(GO:0071548) |
| 0.5 |
0.5 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.5 |
2.3 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.5 |
5.1 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.5 |
6.5 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.5 |
8.8 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.5 |
1.4 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.5 |
7.8 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.5 |
0.5 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.5 |
0.9 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 0.5 |
0.9 |
GO:0097491 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.5 |
0.5 |
GO:1905065 |
regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.5 |
4.1 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.5 |
1.8 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.5 |
5.4 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.5 |
4.1 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.5 |
2.3 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.4 |
1.3 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.4 |
0.9 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.4 |
3.6 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.4 |
8.9 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.4 |
2.6 |
GO:0006085 |
acetyl-CoA biosynthetic process(GO:0006085) |
| 0.4 |
1.8 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.4 |
1.3 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.4 |
4.8 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.4 |
2.2 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.4 |
3.9 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.4 |
4.8 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.4 |
2.1 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.4 |
1.7 |
GO:1903984 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.4 |
2.1 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.4 |
4.2 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.4 |
4.2 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.4 |
5.9 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.4 |
3.4 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.4 |
0.4 |
GO:0033091 |
positive regulation of immature T cell proliferation(GO:0033091) |
| 0.4 |
3.8 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.4 |
1.7 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.4 |
2.1 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.4 |
0.4 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.4 |
0.4 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.4 |
5.4 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.4 |
4.6 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.4 |
2.1 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.4 |
9.0 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.4 |
3.3 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.4 |
12.3 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.4 |
3.7 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.4 |
2.0 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.4 |
10.2 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.4 |
7.3 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.4 |
1.6 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.4 |
1.6 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.4 |
1.2 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.4 |
3.6 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.4 |
3.6 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.4 |
0.8 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.4 |
0.8 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.4 |
0.4 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.4 |
2.0 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.4 |
1.2 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.4 |
0.4 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.4 |
18.2 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.4 |
4.3 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.4 |
1.2 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.4 |
1.2 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.4 |
2.3 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.4 |
1.6 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.4 |
0.8 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.4 |
1.5 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.4 |
1.5 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.4 |
1.1 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.4 |
0.4 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.4 |
1.1 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.4 |
4.5 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.4 |
2.3 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.4 |
0.4 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.4 |
1.1 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.4 |
1.1 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.4 |
1.5 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.4 |
1.8 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.4 |
1.5 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.4 |
0.4 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.4 |
1.5 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.4 |
1.4 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.4 |
1.8 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.4 |
4.0 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.4 |
0.4 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.4 |
1.1 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.4 |
1.1 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.4 |
0.4 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.4 |
1.1 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.4 |
0.4 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 0.4 |
0.7 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.4 |
2.5 |
GO:0033504 |
floor plate development(GO:0033504) |
| 0.4 |
0.4 |
GO:0046785 |
microtubule polymerization(GO:0046785) |
| 0.3 |
0.3 |
GO:2000209 |
regulation of anoikis(GO:2000209) |
| 0.3 |
1.4 |
GO:0046476 |
glycosylceramide biosynthetic process(GO:0046476) |
| 0.3 |
1.4 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.3 |
1.7 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.3 |
0.7 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.3 |
1.0 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.3 |
1.4 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 0.3 |
3.5 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.3 |
0.3 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.3 |
0.3 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.3 |
1.4 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.3 |
1.4 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.3 |
1.0 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.3 |
0.7 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.3 |
7.4 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.3 |
2.7 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.3 |
4.0 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.3 |
1.0 |
GO:0032459 |
regulation of protein oligomerization(GO:0032459) |
| 0.3 |
1.7 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.3 |
1.7 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.3 |
0.7 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.3 |
1.0 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.3 |
3.3 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.3 |
2.3 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.3 |
0.7 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.3 |
1.6 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.3 |
0.7 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.3 |
2.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.3 |
2.0 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.3 |
2.6 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.3 |
1.6 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.3 |
1.0 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.3 |
1.3 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.3 |
0.3 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.3 |
2.6 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.3 |
1.0 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.3 |
0.6 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.3 |
2.3 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.3 |
0.6 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.3 |
1.0 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.3 |
0.6 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.3 |
1.0 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.3 |
1.3 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.3 |
1.3 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.3 |
2.2 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.3 |
0.3 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.3 |
1.6 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.3 |
0.6 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine transport(GO:0015870) acetylcholine secretion(GO:0061526) acetate ester transport(GO:1901374) |
| 0.3 |
1.9 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.3 |
0.6 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
| 0.3 |
2.2 |
GO:0009186 |
deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.3 |
0.9 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.3 |
2.2 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.3 |
0.9 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.3 |
0.3 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.3 |
0.3 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.3 |
0.3 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.3 |
0.6 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.3 |
0.6 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.3 |
0.9 |
GO:0034476 |
U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.3 |
0.9 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 |
0.3 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.3 |
2.4 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.3 |
1.5 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.3 |
0.3 |
GO:1990414 |
cellular response to camptothecin(GO:0072757) replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.3 |
0.6 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.3 |
1.5 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.3 |
0.6 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.3 |
1.5 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.3 |
1.2 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.3 |
4.7 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.3 |
1.8 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.3 |
0.3 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.3 |
0.3 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.3 |
0.9 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.3 |
0.3 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.3 |
1.2 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) fatty-acyl-CoA catabolic process(GO:0036115) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.3 |
2.0 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.3 |
0.3 |
GO:0001821 |
histamine secretion(GO:0001821) |
| 0.3 |
0.3 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.3 |
1.7 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.3 |
0.9 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.3 |
7.8 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.3 |
3.4 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.3 |
2.3 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.3 |
0.6 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.3 |
1.4 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.3 |
1.1 |
GO:0033574 |
response to testosterone(GO:0033574) |
| 0.3 |
0.8 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.3 |
0.6 |
GO:0007320 |
insemination(GO:0007320) |
| 0.3 |
0.6 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.3 |
4.7 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.3 |
1.1 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.3 |
0.6 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.3 |
0.8 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.3 |
1.1 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.3 |
1.1 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.3 |
1.7 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.3 |
1.9 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.3 |
0.3 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.3 |
1.4 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.3 |
0.3 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.3 |
2.7 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.3 |
1.9 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 |
0.8 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.3 |
0.3 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.3 |
0.8 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.3 |
1.6 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.3 |
0.3 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.3 |
0.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.3 |
1.1 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.3 |
0.5 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
7.4 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.3 |
0.8 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.3 |
3.7 |
GO:0034311 |
diol metabolic process(GO:0034311) |
| 0.3 |
0.3 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.3 |
0.8 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 |
2.6 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.3 |
0.8 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.3 |
0.3 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.3 |
3.6 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.3 |
0.5 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.3 |
2.8 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.3 |
1.0 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.3 |
1.3 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.3 |
0.8 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.3 |
0.3 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.3 |
0.8 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.3 |
0.8 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 |
1.3 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.3 |
1.3 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.3 |
2.0 |
GO:1903333 |
negative regulation of protein folding(GO:1903333) |
| 0.3 |
0.8 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.3 |
1.0 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.3 |
1.5 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.3 |
0.5 |
GO:1903421 |
regulation of synaptic vesicle recycling(GO:1903421) |
| 0.2 |
0.2 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.2 |
0.5 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.2 |
0.2 |
GO:0032740 |
positive regulation of interleukin-17 production(GO:0032740) |
| 0.2 |
0.5 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.2 |
0.5 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.2 |
0.2 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.2 |
7.4 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 |
1.2 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 |
0.7 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 |
0.7 |
GO:0002691 |
regulation of cellular extravasation(GO:0002691) |
| 0.2 |
1.7 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 |
0.7 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.2 |
1.4 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.2 |
0.2 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.2 |
3.6 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 |
0.7 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.2 |
1.4 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.2 |
1.7 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.2 |
0.7 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.2 |
1.7 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 |
0.7 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.2 |
0.7 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.2 |
0.5 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.2 |
3.2 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.2 |
1.4 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 |
0.5 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.2 |
1.4 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.2 |
0.5 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 |
0.5 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.2 |
1.6 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.2 |
5.9 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.2 |
3.4 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.2 |
1.1 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 |
0.7 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.2 |
1.6 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
1.4 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.2 |
0.7 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
0.9 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.2 |
4.7 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.2 |
1.6 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.2 |
0.9 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.2 |
2.2 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.2 |
1.1 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.2 |
0.9 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.2 |
0.4 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.2 |
0.9 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.2 |
0.9 |
GO:0034115 |
negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.2 |
1.3 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 |
0.4 |
GO:0070093 |
negative regulation of glucagon secretion(GO:0070093) |
| 0.2 |
0.6 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.2 |
0.2 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.2 |
2.4 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.2 |
0.2 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.2 |
0.6 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 |
4.5 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 |
0.6 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.2 |
0.4 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.2 |
0.2 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.2 |
0.6 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.2 |
0.2 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.2 |
1.5 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.2 |
1.5 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.2 |
2.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 |
1.0 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 |
0.8 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.2 |
0.6 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
1.6 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 |
0.6 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.2 |
1.2 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.2 |
0.2 |
GO:0071047 |
nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.2 |
0.2 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.2 |
1.4 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.2 |
1.2 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.2 |
0.4 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
1.0 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.2 |
0.2 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.2 |
0.2 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 |
2.8 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.2 |
1.0 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.2 |
0.6 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 |
1.0 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.2 |
0.8 |
GO:0002675 |
positive regulation of acute inflammatory response(GO:0002675) |
| 0.2 |
1.8 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.2 |
0.8 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.2 |
0.8 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.2 |
0.4 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.2 |
1.2 |
GO:0032493 |
response to bacterial lipoprotein(GO:0032493) |
| 0.2 |
0.6 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.2 |
0.4 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.2 |
1.6 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.2 |
0.6 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.2 |
1.4 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.2 |
0.6 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.2 |
1.6 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.2 |
0.8 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.2 |
1.0 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
0.6 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.2 |
0.6 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.2 |
1.4 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
1.0 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) negative regulation of interferon-beta production(GO:0032688) |
| 0.2 |
1.8 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.2 |
2.1 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.2 |
2.1 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.2 |
1.1 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.2 |
3.4 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.2 |
0.2 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.2 |
0.9 |
GO:0032306 |
regulation of prostaglandin secretion(GO:0032306) |
| 0.2 |
0.4 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 |
1.1 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.2 |
2.4 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.2 |
1.5 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.2 |
2.4 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.2 |
8.5 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.2 |
0.4 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 |
2.0 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 |
0.2 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.2 |
0.7 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.2 |
1.7 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 |
1.8 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.2 |
0.2 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
| 0.2 |
0.5 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.2 |
1.4 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.2 |
0.4 |
GO:0061341 |
epicardial cell to mesenchymal cell transition(GO:0003347) non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.2 |
0.7 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.2 |
0.2 |
GO:0070857 |
regulation of bile acid biosynthetic process(GO:0070857) |
| 0.2 |
1.1 |
GO:0009264 |
deoxyribonucleotide catabolic process(GO:0009264) |
| 0.2 |
1.1 |
GO:0003056 |
regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.2 |
1.1 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.2 |
0.2 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.2 |
0.2 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.2 |
1.4 |
GO:0042832 |
response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.2 |
1.4 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
| 0.2 |
1.4 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 |
0.5 |
GO:0070670 |
response to interleukin-4(GO:0070670) |
| 0.2 |
0.5 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.2 |
1.0 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 |
0.7 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 |
2.7 |
GO:0035510 |
DNA dealkylation(GO:0035510) |
| 0.2 |
0.5 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.2 |
0.3 |
GO:1904238 |
pericyte cell differentiation(GO:1904238) |
| 0.2 |
0.5 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.2 |
0.3 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.2 |
0.7 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.2 |
0.5 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.2 |
0.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 |
2.7 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
1.3 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.2 |
1.0 |
GO:0051461 |
corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 |
0.3 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 |
0.5 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.2 |
0.2 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.2 |
1.0 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
0.3 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.2 |
0.7 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.2 |
0.2 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 0.2 |
3.8 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.2 |
0.3 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.2 |
1.1 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.2 |
0.6 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 |
0.2 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.2 |
0.5 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.2 |
1.1 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
0.2 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.2 |
0.5 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.2 |
0.3 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.2 |
5.9 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.2 |
0.3 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.2 |
0.5 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.2 |
0.3 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.2 |
0.3 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.2 |
0.3 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.2 |
0.5 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 |
1.4 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.2 |
1.7 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.2 |
0.2 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.2 |
0.3 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.2 |
0.8 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.2 |
0.2 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.2 |
0.3 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.2 |
0.6 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.2 |
0.2 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.2 |
0.3 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.2 |
0.6 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.2 |
1.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.2 |
1.5 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
0.9 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.2 |
2.1 |
GO:0007549 |
dosage compensation(GO:0007549) |
| 0.2 |
0.8 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.2 |
0.9 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.2 |
0.2 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 0.2 |
0.5 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 |
0.6 |
GO:0006833 |
water transport(GO:0006833) |
| 0.2 |
2.6 |
GO:1902855 |
regulation of nonmotile primary cilium assembly(GO:1902855) |
| 0.2 |
2.3 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.2 |
0.5 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.1 |
1.0 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.1 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.1 |
3.3 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 |
0.3 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 0.1 |
0.3 |
GO:0002517 |
T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) |
| 0.1 |
0.9 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 |
5.2 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.1 |
0.3 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 |
1.5 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.1 |
0.6 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 |
0.7 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 |
0.3 |
GO:0034143 |
regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
| 0.1 |
7.9 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.1 |
0.3 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.1 |
3.9 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.6 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
0.4 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.1 |
0.1 |
GO:0055024 |
regulation of cardiac muscle tissue development(GO:0055024) |
| 0.1 |
1.4 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
1.5 |
GO:1903319 |
positive regulation of protein maturation(GO:1903319) |
| 0.1 |
2.2 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.1 |
1.7 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
2.5 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
1.2 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.7 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.1 |
0.1 |
GO:0072148 |
epithelial cell fate commitment(GO:0072148) |
| 0.1 |
1.1 |
GO:0031577 |
spindle checkpoint(GO:0031577) |
| 0.1 |
0.3 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.1 |
0.1 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.5 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) regulation of cholesterol import(GO:0060620) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) regulation of sterol import(GO:2000909) positive regulation of sterol import(GO:2000911) |
| 0.1 |
2.2 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.5 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) specification of axis polarity(GO:0065001) |
| 0.1 |
1.3 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.1 |
0.4 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
1.6 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.1 |
0.4 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.1 |
0.8 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.1 |
0.4 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.3 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.5 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.9 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
1.3 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.5 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.1 |
0.1 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.1 |
0.4 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.1 |
2.1 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
0.3 |
GO:0016093 |
polyprenol metabolic process(GO:0016093) |
| 0.1 |
0.7 |
GO:1901724 |
positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.1 |
0.1 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.1 |
1.7 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
1.3 |
GO:0070193 |
synaptonemal complex organization(GO:0070193) |
| 0.1 |
1.2 |
GO:0045932 |
negative regulation of muscle contraction(GO:0045932) |
| 0.1 |
0.4 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.1 |
0.3 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.8 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.1 |
0.1 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 |
0.8 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 |
0.5 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.1 |
0.3 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
0.1 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.1 |
0.1 |
GO:0071609 |
chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.1 |
0.6 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.1 |
0.1 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.1 |
0.1 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
1.6 |
GO:0061615 |
glycolytic process through fructose-6-phosphate(GO:0061615) |
| 0.1 |
0.1 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.1 |
0.4 |
GO:1902277 |
pancreatic amylase secretion(GO:0036395) regulation of pancreatic amylase secretion(GO:1902276) negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.1 |
0.1 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.1 |
2.1 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.1 |
1.0 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
5.2 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.1 |
0.2 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.7 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 |
0.2 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.1 |
0.4 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
1.3 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 |
1.3 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
0.5 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 |
4.3 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
0.8 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.1 |
1.1 |
GO:0009226 |
nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.1 |
0.4 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.1 |
1.4 |
GO:0090504 |
epiboly(GO:0090504) |
| 0.1 |
0.6 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 |
0.4 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.1 |
0.1 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.1 |
0.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 |
0.5 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.1 |
2.4 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.1 |
0.5 |
GO:0036499 |
PERK-mediated unfolded protein response(GO:0036499) |
| 0.1 |
0.2 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.1 |
0.3 |
GO:0000429 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
| 0.1 |
0.5 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 0.1 |
0.2 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.1 |
1.0 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.1 |
0.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.1 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.1 |
0.1 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.1 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 |
0.4 |
GO:0042267 |
natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.1 |
0.4 |
GO:0070827 |
chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.4 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.1 |
3.4 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
3.2 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 |
0.8 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.3 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
| 0.1 |
0.2 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
0.3 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
0.3 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.1 |
0.8 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.2 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 |
0.4 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
0.1 |
GO:0009838 |
abscission(GO:0009838) |
| 0.1 |
4.3 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.1 |
0.6 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
0.3 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
0.4 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.1 |
5.2 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.1 |
0.7 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 |
0.2 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.1 |
0.1 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.1 |
0.4 |
GO:0019054 |
modulation by virus of host process(GO:0019054) |
| 0.1 |
0.3 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.1 |
1.8 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.1 |
0.4 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.4 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
3.0 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 |
2.3 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
0.3 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.2 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 |
0.6 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.1 |
0.9 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 |
0.1 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.1 |
0.3 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 |
1.6 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.6 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.1 |
0.2 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
0.3 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.1 |
0.9 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.1 |
0.1 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.1 |
0.2 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.1 |
0.4 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.1 |
0.3 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.1 |
0.3 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.6 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.1 |
0.5 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
1.8 |
GO:0048024 |
regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.1 |
0.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.5 |
GO:0003044 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) regulation of systemic arterial blood pressure mediated by a chemical signal(GO:0003044) |
| 0.1 |
0.2 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.1 |
0.4 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.1 |
0.5 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 |
0.2 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 |
0.2 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.1 |
0.5 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.1 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.1 |
1.2 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.1 |
0.2 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.1 |
0.6 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
0.3 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.1 |
0.6 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.1 |
0.2 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
0.2 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 |
0.6 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.2 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
0.3 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
1.2 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.1 |
0.3 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.1 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
0.4 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.5 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
0.3 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.1 |
1.2 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.1 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.1 |
0.4 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 |
0.2 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.1 |
0.9 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.1 |
0.1 |
GO:0014832 |
urinary bladder smooth muscle contraction(GO:0014832) |
| 0.1 |
1.1 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.1 |
1.0 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.2 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 |
0.3 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
1.2 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
0.7 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 |
0.7 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.1 |
1.4 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.1 |
0.1 |
GO:0035384 |
thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
| 0.1 |
1.6 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.1 |
0.2 |
GO:0021933 |
cerebellar cortex maturation(GO:0021699) radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.1 |
0.4 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
1.1 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.1 |
0.6 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
0.2 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 |
0.5 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.1 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 |
0.5 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.1 |
0.2 |
GO:0045842 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.1 |
0.2 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.1 |
0.4 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.9 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 |
0.3 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.5 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
0.2 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.1 |
0.6 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
0.8 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.4 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.1 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 |
1.1 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.1 |
0.2 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.1 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.1 |
0.7 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 |
0.7 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
0.4 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.1 |
1.9 |
GO:0031110 |
regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.1 |
0.2 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 |
0.2 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 |
0.1 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.1 |
0.1 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 |
0.2 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.1 |
0.3 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
0.4 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
0.5 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
0.3 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
1.7 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.1 |
0.4 |
GO:0006312 |
mitotic recombination(GO:0006312) |
| 0.1 |
0.3 |
GO:0036344 |
platelet morphogenesis(GO:0036344) |
| 0.1 |
0.6 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
0.3 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 |
0.1 |
GO:0043489 |
RNA stabilization(GO:0043489) |
| 0.1 |
0.1 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.1 |
2.6 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.3 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
1.5 |
GO:0070265 |
necrotic cell death(GO:0070265) |
| 0.1 |
0.8 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
1.7 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.1 |
0.1 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
0.8 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.1 |
0.1 |
GO:0090086 |
regulation of protein deubiquitination(GO:0090085) negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
0.6 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
1.6 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
0.6 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.4 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.1 |
0.2 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 |
0.5 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.1 |
0.6 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
| 0.1 |
0.1 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
0.2 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.2 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
1.0 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 |
0.9 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
1.0 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
0.3 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
1.7 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.4 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
0.2 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.2 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
0.1 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 |
0.2 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
0.2 |
GO:0060972 |
left/right pattern formation(GO:0060972) |
| 0.1 |
0.6 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.1 |
0.7 |
GO:1902622 |
regulation of neutrophil migration(GO:1902622) |
| 0.1 |
2.3 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.1 |
0.1 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.2 |
GO:0009129 |
pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
| 0.1 |
0.3 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) |
| 0.1 |
0.1 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.1 |
0.3 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 |
0.4 |
GO:1900364 |
regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 |
0.7 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.1 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.1 |
0.7 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.1 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
0.7 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.2 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
0.8 |
GO:0006220 |
pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.1 |
0.7 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
1.5 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.1 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.1 |
0.1 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.9 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
0.3 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.3 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.1 |
0.4 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.0 |
0.2 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.0 |
0.6 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.3 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.0 |
0.1 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.0 |
0.1 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.0 |
1.4 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.0 |
0.1 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.0 |
0.2 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.0 |
0.3 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 |
0.2 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.0 |
1.3 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.1 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.0 |
0.1 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.0 |
0.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
1.1 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.0 |
0.3 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.0 |
0.1 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.0 |
0.1 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.0 |
0.7 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
0.2 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
0.1 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.0 |
0.8 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.0 |
0.1 |
GO:0071622 |
regulation of granulocyte chemotaxis(GO:0071622) |
| 0.0 |
0.3 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.1 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
1.4 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.1 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.0 |
0.7 |
GO:0002455 |
humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.0 |
0.0 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.0 |
0.1 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.0 |
0.5 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.0 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.0 |
0.9 |
GO:0043039 |
tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
| 0.0 |
0.3 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.0 |
1.3 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.2 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.0 |
0.0 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.0 |
0.0 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.3 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
1.4 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.1 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.0 |
0.0 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.0 |
0.1 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 |
0.0 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.0 |
0.2 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.0 |
0.1 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.0 |
0.1 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.4 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.0 |
0.3 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.0 |
0.1 |
GO:0019730 |
antimicrobial humoral response(GO:0019730) |
| 0.0 |
0.4 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.0 |
0.1 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.0 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.0 |
0.1 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.0 |
0.2 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.0 |
0.1 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.0 |
0.0 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.0 |
0.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.4 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 |
0.1 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.0 |
0.1 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.0 |
0.2 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.0 |
0.5 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.1 |
GO:0021826 |
substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.0 |
0.2 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.1 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.0 |
2.9 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.3 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.0 |
0.3 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.0 |
0.1 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.1 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.0 |
0.1 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.0 |
0.1 |
GO:0090049 |
regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
| 0.0 |
0.2 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.0 |
0.1 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 |
0.1 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.0 |
0.0 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.0 |
0.1 |
GO:1902308 |
regulation of peptidyl-serine dephosphorylation(GO:1902308) |
| 0.0 |
0.1 |
GO:0002828 |
regulation of type 2 immune response(GO:0002828) |
| 0.0 |
0.6 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.2 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.1 |
GO:0006956 |
complement activation(GO:0006956) |
| 0.0 |
0.0 |
GO:0009214 |
cyclic nucleotide catabolic process(GO:0009214) |
| 0.0 |
0.1 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.0 |
0.0 |
GO:0051971 |
positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.0 |
0.0 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.0 |
0.2 |
GO:0032210 |
regulation of telomere maintenance via telomerase(GO:0032210) |
| 0.0 |
0.0 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.0 |
0.0 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.0 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.1 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.0 |
0.1 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 |
0.3 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
0.1 |
GO:2000193 |
positive regulation of fatty acid transport(GO:2000193) |
| 0.0 |
0.1 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.1 |
GO:0044838 |
cell quiescence(GO:0044838) |
| 0.0 |
0.2 |
GO:0098907 |
T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) regulation of atrial cardiac muscle cell action potential(GO:0098910) |
| 0.0 |
0.2 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.0 |
0.2 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.0 |
0.1 |
GO:0060312 |
regulation of blood vessel remodeling(GO:0060312) |
| 0.0 |
0.2 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.1 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.0 |
0.0 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.0 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.0 |
0.0 |
GO:0010934 |
macrophage cytokine production(GO:0010934) |
| 0.0 |
0.2 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 |
0.1 |
GO:0043921 |
modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
| 0.0 |
0.1 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.0 |
0.6 |
GO:0000910 |
cytokinesis(GO:0000910) |
| 0.0 |
0.0 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.2 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 |
0.0 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.0 |
0.1 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.1 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.2 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
0.0 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.0 |
0.2 |
GO:1903317 |
regulation of protein maturation(GO:1903317) |
| 0.0 |
0.1 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.0 |
0.3 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.3 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.0 |
GO:0016598 |
protein arginylation(GO:0016598) |
